MediCapital Rent announces expansion and changes in managementWednesday, November 13, 2019
Jeroen Kok, MediCapital Rent founder and CEO comments: “We are very pleased to welcome Gryphion as a partner. This will allow us to solidify and grow our position in the CRO, Pharma and Biotech R&D segment and facilitate our expansion plans in the Asia-Pacific region.”
Additionally, MediCapital Rent announced that John Blank, an experienced CRO executive has been appointed as the new CEO. Furthermore Ramon van Maaren (Director USA) and Rob Jan Klein Bog (Director Operations) have been appointed to the Executive Management Board.
MediCapital Rent was founded in Leiden, the Netherlands by mr. Jeroen Kok and mrs. Joanna Kok-Szymanska in 1996.
“Our business philosophy of truly ‘walking the talk’ that we have applied since the inception of our company, has proven to be very successful”, said the Founding Chairman Jeroen Kok. “Our historical success rates and growth path combined with our plans for expansion of services and development in the APAC region, helped us to attract investment capital allowing us to accelerate our plans. This deal will ensure that we will have the financial bandwidth necessary to meet the increasing demands of our CRO, Pharma and Biotech customers for the years to come.”
Jeroen continued: “In the current phase of our growth we were very pleased with John Blank’s expertise in the global Clinical Trial market, particularly services related to Clinical Trial Diagnostics. This expertise in conjunction with his general management experience obtained at leading CROs, make John the perfect match to join our Executive Management Board.”
John Blank added: “I am very proud to be joining a well-established and fast growing organization that is so highly focused on quality, while continually delivering services as promised. I am very much looking forward to supporting the ambitious plans for the future, including our global expansion plans. In doing so, we will be better positioned to support even more studies and their investigators, wherever they are located.”
Hans Oerlemans, Managing Director of Gryphion concluded: ”Gryphion is excited to support further growth of MediCapital Rent as the company has demonstrated to be a reliable and dedicated partner for its customers and is very well positioned to add more value-added services.
As an entrepreneurial family office, we have extensive global networks and access to expertise, and are fully committed to supporting the global growth ambitions.”
MediCapital Rent is a world leading supplier of medical rentals for clinical trials, providing full, global logistics services to suit. MediCapital Rent leverages 20 years of experience in the clinical trials business to offer customers total peace of mind – getting the right equipment, related supplies, and documentation to the right place at the right time. Today, the portfolio covers a wide range of medical equipment and ancillary supplies that have been successfully deployed for hundreds of studies to more than 10,000 sites globally, from centrifuges to ultralow freezers for processing and storing samples, and from in-house calibrated infusion pumps to pre-configured diagnostic ECG machines. MediCapital Rent has offices in Leiden, the Netherlands, Atlanta (GA) in the USA, and Zug in Switzerland. (www.medicapitalrent.com)
Formed in 2018, Gryphion is a family investment platform investing in multiple asset classes, predominantly in Western Europe and is operating out of Amsterdam, with offices in Antwerp and London. Defined by flexibility and not by exit-pressures, Gryphion primarily makes direct investments or large-scale co-investments in businesses with high growth potential, providing management teams, founders, and entrepreneurs with long-term capital, industry-leading private equity experience, and operational expertise. (www.gfo.nu)